M
2.62
0.05 (1.99%)
| Penutupan Terdahulu | 2.57 |
| Buka | 2.59 |
| Jumlah Dagangan | 128,872 |
| Purata Dagangan (3B) | 174,373 |
| Modal Pasaran | 13,547,941 |
| Harga / Jualan (P/S) | 5.40 |
| Harga / Buku (P/B) | 0.620 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -2,264.62% |
| EPS Cair (TTM) | -4.84 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -56.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.54% |
| Nisbah Semasa (MRQ) | 0.050 |
| Aliran Tunai Operasi (OCF TTM) | -4.86 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.09 M |
| Pulangan Atas Aset (ROA TTM) | -62.72% |
| Pulangan Atas Ekuiti (ROE TTM) | -118.31% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Menurun | Bercampur |
| Health Information Services (Global) | Menurun | Bercampur | |
| Stok | Mangoceuticals, Inc. | - | - |
AISkor Stockmoo
-1.3
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -2.5 |
| Purata | -1.25 |
|
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men’s wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| % Dimiliki oleh Orang Dalam | 24.27% |
| % Dimiliki oleh Institusi | 1.18% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Ackerman Capital Advisors, Llc | 31 Dec 2024 | 34,500 |
| Mccollum Christoferson Group Llc | 31 Dec 2024 | 0 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |